Comparison of hepatic enzymes between Japanese men with and without metabolic syndrome

Acta Medica Okayama

Volumn 61, Issue 1, 2007, Pages 31-34

  Miyatake, Nobuyuki ^a   Matsumoto, Sumiko ^a   Makino, Hirofumi ^b   Numata, Takeyuki ^a  

^a Okayama Southern Institute of Health   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Hepatic enzymes; Metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; ASIAN; COHORT ANALYSIS; COMPARATIVE STUDY; ENZYMOLOGY; ETHNOLOGY; FEMALE; HUMAN; LIVER; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED;

ADULT; AGED; ALANINE TRANSAMINASE; ASIAN CONTINENTAL ANCESTRY GROUP; ASPARTATE AMINOTRANSFERASES; COHORT STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 33947209999     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Miyatake N, Kawasaki Y, Nishikawa H, Takenami S and Numata T: Prevalence of metabolic syndrome in Okayama prefecture, Japan. Intern Med (2006) 45: 107-108.
2. An examination committee for criterion of metabolic syndrome: Definition and criteria of metabolic syndrome. Nippon Naika Gakkai Zasshi (2005) 94: 794-809 (in Japanese).
3. Brunt EM: Nonalcoholic steatohepatitis. Semin Liver Dis (2004) 24: 3-20.
4. Wannamethee SG, Shaper AG, Lennon L and Whincup PH: Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care (2005) 28: 2913-2918.
5. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, Stern MP and Ferrannini E: Mexico City diabetes study: Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care (2005) 28: 1757-1762.
6. Lewis GF, Carpentier A, Adeli K and Giacca A: Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev (2002) 23: 201-229.
7. Unger RH: Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology (2003) 144: 5159-5165.
8. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y and Funahashi T: Adiponectin as a biomarker of the metabolic syndrome. Circ J (2004) 68: 975-981.
9. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A and George J: Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology (2004) 40: 46-54.